Clinical Variability in Approaches to Polycystic Ovary Syndrome

Journal of Pediatric and Adolescent Gynecology

Volumn 25, Issue 4, 2012, Pages 259-261

  Bonny, Andrea E ^a   Appelbaum, Heather ^b   Connor, Ellen Lancon ^c   Cromer, Barbara ^d   DiVasta, Amy ^e   Gomez Lobo, Veronica ^f   Harel, Ze'ev ^g   Huppert, Jill ^h   Sucato, Gina ⁱ  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f GEORGETOWN UNIVERSITY   (United States)

^g BROWN UNIVERSITY   (United States)

^h CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Adolescent; Diagnosis; Polycystic ovary syndrome; Treatment

Indexed keywords

ANDROSTENEDIONE; ESTRADIOL; FOLLITROPIN; HEMOGLOBIN A1C; HYDROXYPROGESTERONE; INSULIN; LIPID; LUTEINIZING HORMONE; METFORMIN; ORAL CONTRACEPTIVE AGENT; PRASTERONE SULFATE; PROLACTIN; SEX HORMONE BINDING GLOBULIN; SPIRONOLACTONE; TESTOSTERONE; THYROTROPIN; THYROXINE;

ANDROGEN BLOOD LEVEL; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; CLINICAL PRACTICE; CROSS-SECTIONAL STUDY; DIET; ESTRADIOL BLOOD LEVEL; EXERCISE; FOLLITROPIN BLOOD LEVEL; GESTAGEN BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INTERNET; LIPID BLOOD LEVEL; LUTEINIZING HORMONE BLOOD LEVEL; ORAL CONTRACEPTION; OVARY POLYCYSTIC DISEASE; PILOT STUDY; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROTEIN BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

ADOLESCENT; CONTRACEPTIVES, ORAL; CROSS-SECTIONAL STUDIES; DATA COLLECTION; EXERCISE; FEMALE; FOOD HABITS; HORMONES; HUMANS; HYPOGLYCEMIC AGENTS; METABOLIC SYNDROME X; METFORMIN; MINERALOCORTICOID RECEPTOR ANTAGONISTS; PHYSICIAN'S PRACTICE PATTERNS; POLYCYSTIC OVARY SYNDROME; REFERRAL AND CONSULTATION; SEX HORMONE-BINDING GLOBULIN; SPIRONOLACTONE;

EID: 84864320087     PISSN: 10833188     EISSN: 18734332     Source Type: Journal    
DOI: 10.1016/j.jpag.2012.03.004     Document Type: Article

References (9)

1. Chen X., Yang D., Mo Y., et al. Prevalence of polycystic ovary syndrome in unselected women from southern China. Eur J Obstet Gynecol Reprod Biol 2008, 139:59.
2. Michelmore K.F., Balen A.H., Dunger D.B., et al. Polycystic ovaries and associated clinical and biochemical features in young women. Clin Endocrinol (Oxf) 1999, 51:779.
3. Asunción M., Calvo R.M., San Millán J.L., et al. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000, 85:2434.
4. Azziz R., Woods K.S., Reyna R., et al. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004, 89:2745.
5. Diamanti-Kandarakis E., Kouli C.R., Bergiele A.T., et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 1999, 84:4006.
6. Knochenhauer E.S., Key T.J., Kahsar-Miller M., et al. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998, 83:3078.
7. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004, 81:19. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group.
8. Azziz R., Carmina E., Dewailly D., et al. Task Force on the Phenotype of the Polycystic Ovary Syndrome of The Androgen Excess and PCOS Society: The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 2009, 91:456.
9. Krassas G.E., Pontikides N., Kaltsas T., et al. Disturbances of menstruation in hypothyroidism. Clin Endocrinol (Oxf) 1999, 50:655.